Cargando…

Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection

Hepatic parenchymal disease, including chronic viral hepatitis, has traditionally been considered a relative contraindication to islet transplantation as the islets are infused into the recipient’s liver. We present a case study of a patient with treated chronic hepatitis C infection (HCV) who safel...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajab, Amer, Buss, Jill, Hart, Phil A., Conwell, Darwin, Lara, Luis, Meng, Shumei, Kuntz, Kristin, Black, Sylvester, Washburn, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180727/
https://www.ncbi.nlm.nih.gov/pubmed/30203686
http://dx.doi.org/10.1177/0963689718796772
_version_ 1783362267932262400
author Rajab, Amer
Buss, Jill
Hart, Phil A.
Conwell, Darwin
Lara, Luis
Meng, Shumei
Kuntz, Kristin
Black, Sylvester
Washburn, Ken
author_facet Rajab, Amer
Buss, Jill
Hart, Phil A.
Conwell, Darwin
Lara, Luis
Meng, Shumei
Kuntz, Kristin
Black, Sylvester
Washburn, Ken
author_sort Rajab, Amer
collection PubMed
description Hepatic parenchymal disease, including chronic viral hepatitis, has traditionally been considered a relative contraindication to islet transplantation as the islets are infused into the recipient’s liver. We present a case study of a patient with treated chronic hepatitis C infection (HCV) who safely received an autologous islet transplant following total pancreatectomy with excellent clinical outcomes. The patient was a 60-year-old woman diagnosed with debilitating abdominal pain secondary to chronic pancreatitis and with preserved islet function. She had previously been treated >10 years prior to surgical evaluation with interferon monotherapy for 1 year that led to sustained virologic response, including at the time of surgical evaluation for total pancreatectomy and islet autotransplantation (TPIAT). She underwent comprehensive preoperative evaluation of the liver, including liver biopsy, which showed no significant portal inflammation or fibrosis. Following a multidisciplinary meeting and discussion of the potential risks for the patient, the decision was made to proceed with TPIAT. The patient underwent a standard total pancreatectomy, and an autologous islet dose of 6638 islet equivalents/kg body weight was infused into the liver via the portal vein. Portal vein pressure was monitored throughout the infusion with a transient peak pressure of 27 cm H(2)O (basal pressure of 14 cm H(2)O) and final pressure of 23 cm H(2)0 at 10 min post-infusion. Aside from a transient transaminitis, liver enzymes were normal at the time of hospital discharge. At greater than 1 year of follow-up, the patient has improved quality of life, with reduction in narcotic analgesia, remains insulin independent (with normal islet function), and has normal liver function. This case illustrates that islet autotransplant into the liver can be safely performed and suggests that carefully selected patients with liver disease may be eligible for TPIAT.
format Online
Article
Text
id pubmed-6180727
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-61807272018-10-19 Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection Rajab, Amer Buss, Jill Hart, Phil A. Conwell, Darwin Lara, Luis Meng, Shumei Kuntz, Kristin Black, Sylvester Washburn, Ken Cell Transplant Case Study Hepatic parenchymal disease, including chronic viral hepatitis, has traditionally been considered a relative contraindication to islet transplantation as the islets are infused into the recipient’s liver. We present a case study of a patient with treated chronic hepatitis C infection (HCV) who safely received an autologous islet transplant following total pancreatectomy with excellent clinical outcomes. The patient was a 60-year-old woman diagnosed with debilitating abdominal pain secondary to chronic pancreatitis and with preserved islet function. She had previously been treated >10 years prior to surgical evaluation with interferon monotherapy for 1 year that led to sustained virologic response, including at the time of surgical evaluation for total pancreatectomy and islet autotransplantation (TPIAT). She underwent comprehensive preoperative evaluation of the liver, including liver biopsy, which showed no significant portal inflammation or fibrosis. Following a multidisciplinary meeting and discussion of the potential risks for the patient, the decision was made to proceed with TPIAT. The patient underwent a standard total pancreatectomy, and an autologous islet dose of 6638 islet equivalents/kg body weight was infused into the liver via the portal vein. Portal vein pressure was monitored throughout the infusion with a transient peak pressure of 27 cm H(2)O (basal pressure of 14 cm H(2)O) and final pressure of 23 cm H(2)0 at 10 min post-infusion. Aside from a transient transaminitis, liver enzymes were normal at the time of hospital discharge. At greater than 1 year of follow-up, the patient has improved quality of life, with reduction in narcotic analgesia, remains insulin independent (with normal islet function), and has normal liver function. This case illustrates that islet autotransplant into the liver can be safely performed and suggests that carefully selected patients with liver disease may be eligible for TPIAT. SAGE Publications 2018-09-11 2018-10 /pmc/articles/PMC6180727/ /pubmed/30203686 http://dx.doi.org/10.1177/0963689718796772 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Study
Rajab, Amer
Buss, Jill
Hart, Phil A.
Conwell, Darwin
Lara, Luis
Meng, Shumei
Kuntz, Kristin
Black, Sylvester
Washburn, Ken
Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection
title Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection
title_full Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection
title_fullStr Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection
title_full_unstemmed Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection
title_short Total Pancreatectomy and Islet Autotransplantation Following Treated Hepatitis C Infection
title_sort total pancreatectomy and islet autotransplantation following treated hepatitis c infection
topic Case Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180727/
https://www.ncbi.nlm.nih.gov/pubmed/30203686
http://dx.doi.org/10.1177/0963689718796772
work_keys_str_mv AT rajabamer totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT bussjill totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT hartphila totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT conwelldarwin totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT laraluis totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT mengshumei totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT kuntzkristin totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT blacksylvester totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection
AT washburnken totalpancreatectomyandisletautotransplantationfollowingtreatedhepatitiscinfection